Dr. Rosseel - Dr. Westerlinck SRL
Dr. Rosseel - Dr. Westerlinck reported total assets of €1.54m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of Dr. Rosseel - Dr. Westerlinck shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +29 % Total assets +15 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Rosseel - Dr. Westerlinck's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 02 Jul 2025
- Year ended 31 Dec 2023filed on 02 Jul 2024
- Year ended 31 Dec 2022filed on 03 Jul 2023
- Year ended 31 Dec 2021filed on 01 Jul 2022
Dr. Rosseel - Dr. Westerlinck's financial analysis
- Solvency88.8%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Rosseel - Dr. Westerlinck
Dr. Rosseel - Dr. Westerlinck's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0871.031.294
- VAT number
- BE0871031294
- Peppol
- Registered · 0208:0871031294 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Jan 2005
- Registered office
- 3680 Maaseik
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Rosseel - Dr. Westerlinck (SRL) has been based in Maaseik since 2005, active in: medical specialists activities. For 2025, it reports a net profit of 359,305 € and equity of €1.37m; its revenue is not published. Its solvency stands at 88.8%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Rosseel - Dr. Westerlinck
Companies in the same business, of comparable size and area, outside its group.
- RaCé X Immo Business and other management consultancy activities Mons · balance sheet €1.54m
- Sablon-Regence Manufacture of wire products, chain and springs Brussels · balance sheet €1.54m
- L.L. Bati Invest Herve · balance sheet €1.54m
- Veco Knokke-Heist · balance sheet €1.54m
- Immo LVDF Aubange · balance sheet €1.54m
- Vedeco Hulshout · balance sheet €1.54m
- Paul van Haeren Etterbeek · balance sheet €1.54m
Frequently asked questions about Dr. Rosseel - Dr. Westerlinck
What is the revenue of Dr. Rosseel - Dr. Westerlinck?
Dr. Rosseel - Dr. Westerlinck files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Rosseel - Dr. Westerlinck?
In Belgium, the VAT number is the company number prefixed with BE: BE0871031294 for Dr. Rosseel - Dr. Westerlinck, if the company is VAT-registered. Its company number (CBE) is 0871.031.294.
Where is the registered office of Dr. Rosseel - Dr. Westerlinck?
According to the CBE register, the registered office of Dr. Rosseel - Dr. Westerlinck is in 3680 Maaseik.
What is the equity of Dr. Rosseel - Dr. Westerlinck?
At the close of the 2025 financial year, the equity of Dr. Rosseel - Dr. Westerlinck amounts to 1,372,006 €, a solvency of 88.8% of total assets.
Who manages Dr. Rosseel - Dr. Westerlinck?
The register lists 2 active mandates at Dr. Rosseel - Dr. Westerlinck. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Rosseel - Dr. Westerlinck
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →